Satraplatin - Prednisone Combination For Treatment Of Patients With Metastatic Hormone-Refractory…
June 27th, 2007 by admin
Pharmion submitted marketing authorization application Satraplatin in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer who have failed prior chemotherapy.
More: continued here












0 Responses to “Satraplatin - Prednisone Combination For Treatment Of Patients With Metastatic Hormone-Refractory…”